14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACST
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Acasti Pharma stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session.
(Updated on Dec 08, 2023)


Buy candidate since Dec 08, 2023 PDF
The Acasti Pharma stock price fell by -1.0752688172043% on the last day (Friday, 8th Dec 2023) from $2.33 to $2.30. During the last trading day the stock fluctuated 5.41% from a day low at $2.22 to a day high of $2.34. The price has fallen in 6 of the last 10 days but is still up by 8.76% over the past 2 weeks. Volume has increased on the last day by 134 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 7 thousand shares were bought and sold for approximately $17.09 thousand.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.47% during the next 3 months and, with a 90% probability hold a price between $1.62 and $2.77 at the end of this 3-month period.

ACST Signals & Forecast

The Acasti Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.26 and $2.27. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, September 28, 2023, and so far it has fallen -22.03%. Further fall is indicated until a new bottom pivot has been found. Acasti Pharma gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for Acasti Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.18 and $2.01. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Acasti Pharma finds support just below today's level at $2.18. If this is broken, then the next support from accumulated volume will be at $2.01 and $1.77.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.120 between high and low, or 5.41%. For the last week, the stock has had daily average volatility of 7.03%.

Our recommended stop-loss: $2.19 (-4.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 50 days ago.)

Trading Expectations (ACST) For The Upcoming Trading Day Of Monday 11th

For the upcoming trading day on Monday, 11th we expect Acasti Pharma to open at $2.29, and during the day (based on 14 day Average True Range), to move between $2.17 and $2.43, which gives a possible trading interval of +/-$0.129 (+/-5.60%) up or down from last closing price. If Acasti Pharma takes out the full calculated possible swing range there will be an estimated 11.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.41 (4.78%) than the support at $2.18 (5.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Acasti Pharma stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.168 Open Broker Account

Buy Candidate Upgraded

Predicted Opening Price for Acasti Pharma of Monday, December 11, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 11, 2023 Current price
$2.29 $2.30 (Overvalued)

Remember To Visit Our YouTube Channel


Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.41 4.64 %
R2 2.36 2.64 %
R1 2.33 1.41 %
Current price: 2.30
Support S1 2.24 -2.57 %
S2 2.21 -3.80 %
S3 2.17 -5.80 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.78 21.02 %
R2 2.77 20.43 %
R1 2.41 4.78 %
Current price 2.30
Support S1 2.18 -5.22%
S2 2.01 -12.61%
S3 1.77 -23.04%
What is the symbol for Acasti Pharma Stock and on which exchange is it traded?
The symbol for Acasti Pharma is ACST and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Acasti Pharma Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Acasti Pharma Stock?
Acasti Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Acasti Pharma Stock.

What's the current price of Acasti Pharma Stock?
As of the end of day on the 2023-12-08, the price of an Acasti Pharma (ACST) share was $2.30.

What is the 52-week high and low for Acasti Pharma Stock?
The 52-week high for Acasti Pharma Stock is $3.76 and the 52-week low is $0.340.

What is the market capitalization of Acasti Pharma Stock?
As of the 2023-12-08, the market capitalization of Acasti Pharma is 21.619M.

When is the next earnings date for Acasti Pharma?
The upcoming earnings date for Acasti Pharma is 2024-02-13 00:00:00.

Click to get the best stock tips daily for free!

About Acasti Pharma

Acasti Pharma Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.... ACST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT